Impact of genetic and non-genetic factors on hepatic CYP2C9 expression and activity in Hungarian subjects
Abstract CYP2C9, one of the most abundant hepatic cytochrome P450 enzymes, is involved in metabolism of 15–20% of clinically important drugs (warfarin, sulfonylureas, phenytoin, non-steroid anti-inflammatory drugs). To avoid adverse events and/or impaired drug-response, CYP2C9 pharmacogenetic testin...
Enregistré dans:
Auteurs principaux: | Ferenc Fekete, Katalin Mangó, Máté Déri, Evelyn Incze, Annamária Minus, Katalin Monostory |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b6e9c3ef1c064e07b6526c64bf166e4e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients
par: Máté Déri, et autres
Publié: (2021) -
Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis
par: Patrick Vizeli, et autres
Publié: (2021) -
The memorandum of association in the light of the provisions on contracts of the Hungarian Civil Code
par: Mohai Máté I.
Publié: (2021) -
The Influence of CYP2D6 and CYP2C19 Genetic Variation on Diabetes Mellitus Risk in People Taking Antidepressants and Antipsychotics
par: Isabelle Austin-Zimmerman, et autres
Publié: (2021) -
Are cytochrome P450 CYP2C8 and CYP2C9 polymorphisms associated with ibuprofen response in very preterm infants?
par: Xavier Durrmeyer, et autres
Publié: (2010)